Aristopharma Ltd. proudly introduced 1st Time in Bangladesh "Vonofix" the pre...

Vonoprazan fumarate is a Potassium-Competitive Acid Blocker (P-CAB). It binds to the active proton pumps in a non-covalent and reversible manner.

Fellowship Celebration Program of Aristopharma

Fellowship Celebration Program of Aristopharma

Aristopharma Held Annual Sales Conference-2022

Aristopharma Held Annual Sales Conference-2022 & Celebrated the 20th Anniversary of its Ophthalmic Division (ARISTOVISION)

Aristopharma Ltd. sponsors a scientific seminar on “Guideline for Dengue Case...

Aristopharma Ltd. sponsors a scientific seminar on “Guideline for Dengue Case Management”at Radisson Blu, Dhaka.

Aristopharma launches Temcard-A Tablet

Aristopharma launches Temcard-A Tablet which is a fixed dose combination of Telmisartan and Amlodipine.

Aristopharma arranges the grand launching program of Budison-FG

Aristopharma arranges the grand launching program of Budison-FG Inhaler.

Aristopharma launches Budison-FG HFA Inhaler

Budison-FG HFA inhaler is a combination of Budesonide, Formoterol & Glycopyrrolate.

Aristopharma launches Limpa tablet

Limpa is the first antidiabetic treatment of its kind that works in 3 pathways to lower blood sugar with 2 extra CV benefits by 1 single tablet.

Aristopharma Sponsors Cultural Night and Banquet of 21st International Congre...

Aristopharma Sponsors Cultural Night and Banquet of 21st International Congress and Scientific Seminar-2022 of Bangladesh Society of Medicine.

Aristopharma launches Canalia Capsule

Canalia Capsule is the only US FDA approved Proton Pump Inhibitor formulated with Dual Delayed Release (DDR) technology that ensures faster action...

Aristopharma participates in 35th annual scientific congress of BOSCON-2022

Doctors are enjoying our stall activities like dart and mini golf games with snacks and coffee at 35th annual scientific congress of BOSCON-2022 at...

Aristopharma held “Strategic meeting-2022”

Aristopharma Ltd. arranged its “Strategic meeting-2022” on December 30, 2021at Pan Pacific Sonargaon, Dhaka. The program focused on the brand plann...

Aristopharma launches Ariscon suspension

Ariscon Suspension is the superior antacid by action which ensures faster relief from heartburn. Conventional Antacids only neutralizes stomach aci...

Aristopharma introduces new Herbal Division

Aristopharma Ltd. has recently launched their new Herbal Division with a brand new, dedicated Herbal Plant built as per WHO-cGMP guidelines in thei...

Aristopharma has launched Livcare 5 & 10 mg Tablet for the treatment of Non-A...

Livcare (Obeticholic Acid) is a selective Farnesoid X Receptor (FXR) agonist with anticholestatic & hepato-protective properties. Due to these prom...

Aristopharma Held Annual Sales Conference-2019

Aristopharma Ltd., one of the leading pharmaceutical companies of Bangladesh arranged their Annual Sales Conference’19